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Abstract: Treatment of mycetoma depends on the
causative organism and since many organisms, both
actinomycetes (actinomycetoma) and fungi (eumyce-
toma), are capable of producing mycetoma, an accurate
diagnosis is crucial. Currently, multiple diagnostic tools
are used to determine the extent of infections and to
identify the causative agents of mycetoma. These include
various imaging, cytological, histopathological, serologi-
cal, and culture techniques; phenotypic characterisation;
and molecular diagnostics. In this review, we summarize
these techniques and identify their merits and pitfalls in
the identification of the causative agents of mycetoma
and the extent of the disease. We also emphasize the fact
that there is no ideal diagnostic tool available to identify
the causative agents and that future research should
focus on the development of new and reliable diagnostic
tools.
Introduction
Mycetoma is a common medical and health problem in many
tropical and subtropical regions. It is an infection of the
subcutaneous tissues that is caused by actinomycetes (actinomy-
cetoma) or fungi (eumycetoma) and is characterized by the
development of large subcutaneous masses and discharging sinuses
[1]. Within the discharged material, the causative agents are
located both in and outside of grains. The colours of the grains can
often be indicative of the aetiological agent: fungal grains are
usually black or pale, while those of actinomycetes are white,
yellow, or red (Figure 1) [1].
Since both actinomycetes and fungi are implicated as causative
agents, it is important to distinguish them in order to ensure that
correct treatments are given. Actinomycetoma is treated with
antibiotics and eumycetoma with a combination of antifungal
therapy and surgery [2]. The relevance of correct species
identification was emphasised in a recent published case report
in which a patient presented with yellow-grain eumycetoma
caused by the fungus Pleurostomophora ochracea [3]. In the past,
yellow grains were always considered to be of bacterial origin, and
antibacterial, as opposed to antifungal, treatment was started and
found to be ineffective.
In addition to differentiating actinomycetoma and eumycetoma,
it is important to identify causal agents to the species level to
ensure correct antimicrobial therapy. Several actinomycetes and
fungi have been implicated as causative agents of mycetoma [4].
In vitro, not all fungi are equally susceptible to antifungal agents;
for instance, Madurella fahalii is not inhibited by high concentra-
tions of ketoconazole and itraconazole, which are drugs that are
used in the treatment of eumycetoma [5]. Regarding actinomy-
cetoma, therapeutic outcome is based on a prompt and adequate
response to the administered antimicrobials. Actinomycetes
usually respond well to cotrimoxazole, but a combination of this
antibiotic with aminoglycosides is used in advanced cases or in
cases not responding to treatment. Other antibiotics can also be
used. Ideally, sensitivity tests should be done before starting
treatment, namely, shortly after the etiologic agent is isolated.
In this review we summarize the currently used diagnostic tools
and discuss their merits and pitfalls in the diagnosis of mycetoma.
Imaging Technology
An initial diagnosis is made after clinical assessment. Clinical
examination alone does not identify the causative organism nor
does it detect the spread of disease along the different tissue planes
and bone. Imaging techniques, such as radiology, ultrasonogra-
phy, CT scan, and magnetic resonance imaging (MRI) can be
used to determine the extent of lesions.
Conventional radiographs are used to identify the limits of
lesions and to determine if bone is affected (Figure 2A). It is
important to detect if bone is infected as nonsurgical cure is
uncertain in such cases [6]. Several different radiological signs
should be sought. Abd El Bagi suggested a radiographic
classification of mycetoma to determine the extent of lesions
(Table 1) based on radiographic records of 516 patients seen in the
Mycetoma Research Centre, Khartoum, Sudan [7]. It is evident
from this table that with classic radiology, multiple radiological
changes can be detected. This method can be used to show the
presence and extent of soft tissue granulomas [6] and to
demonstrate bone invasion by the causative agent or the
occurrence of pathological fractures [8]. Fractures, however, are
uncommon; of the 517 patients seen in a diagnostic centre in
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Sudan, only 12 patients (2.3%) had pathological fractures [9]; no
correlation was found between bone involvement and the duration
of symptoms [6].
A more specific imaging technique used to detect mycetoma is
ultrasonic imaging (Figure 2B) [10]. This technique is routinely
used in the diagnosis of mycetoma. Mycetoma grains, capsules,
and the accompanying inflammatory granulomata have a
characteristic ultrasonic appearance [10]. Hyper-reflective echoes
were noted only in mycetoma lesions and were recorded as fine
(22%) or sharp (35%), numerous (50%) or few (17%), isolated
(30%) or aggregated (17%), and diffuse (10%) or settled at the
bottom of cavities (22%) [10]. However, when active sinuses are
present in lesions, the identification of these hyper-reflective
echoes are less clear [10]. Due to the presence of these hyper-
reflective echoes, ultrasound imaging can be used to differentiate
between mycetoma and non-mycetoma lesions and between
actinomycetoma and eumycetoma [8,10]. In eumycetoma lesions,
the grains produce numerous sharp bright hyper-reflective echoes,
which correspond to the black grains [8]. It is thought that the
grain cement material is the origin of these sharp echoes. In
actinomycetoma, the echoes obtained from grains are less distinct,
probably due to their smaller size and consistency [8]. Although it
is possible to distinguish between actinomycetoma and eumyce-
toma, it is difficult, if not impossible, to distinguish between
different causative agents [8].
MRI is useful for visualizing soft tissue involvement and bone
destruction (Figure 2C) [8,11,12]. With this technique, grains
appear as conglomerates of small (2–5 mm) round hyperintense
lesions, representing granulation tissue, surrounded by a low-
signal-intensity rim [12]. By correlating MRI data with histological
findings, Sarris et al. showed that the high-signal-intensity foci seen
with MRI represented inflammatory granulomata, while the
central low-signal-intensity dots were caused by grains [13]. The
low-signal-intensity signs were named ‘‘dot-in-circle’’ and were
seen in 80% of patients, which made this appearance highly
indicative of mycetoma [12,14]. In 2012, El Shamy and colleagues
reported a new grading system for MRI diagnosis of mycetoma
[15] in which a score was given for skin, subcutaneous tissue,
muscle, and bone involvement (Table 2) [15]. Mycetoma lesions
can be classified as mild (score 1–3), moderate (score 4–7), or
severe (score 8–10) based on these scores. MRI was not suitable to
discriminate actinomycetoma from eumycetoma, although acti-
nomycetoma more often showed soft tissue microabscesses, bony
periosteal reaction and reactive sclerosis, while eumycetoma
frequently exhibited soft tissue macroabscesses with bone cavita-
tion, such differences were not statistically significant [15].
Themerits of these imaging techniques are that they are fast, non-
invasive, and can easily be used to detect the extent of lesions and
help in planning appropriate treatment strategies. Of the various
techniques discussed above, radiography and ultrasound imaging
are the most applicable in low-income countries and can be used in
local settings, provided that proper training is given. Radiography
should normally be available in most peripheral hospitals, but not
MRI, a situation that hinders the implementation of this latter
Figure 1. Different grains obtained from eumycetoma and actinomycetoma lesions. In this figure different grain types are shown. A: An
eumycetoma surgical excision with numerous black grains, indicative for M. mycetomatis. B: An actinomycetoma surgical biopsy with numerous
yellow grains, indicative for S. somaliensis. C: Grains of Madurella mycetomatis fixed in formalin. D: Histological slide of a Madurella mycetomatis grain
inside subcutaneous tissue. The grain is clearly seen as a round brown structure (arrow) (6100). E: Histological slide of a S. somaliensis grain inside
subcutaneous tissue (arrow) (6400).
doi:10.1371/journal.pntd.0002918.g001
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method in standard diagnosis of mycetoma. When the technique is
available, expertise is needed to differentiate between mycetoma
and bone tuberculosis, granulomas and chronic bacterial osteomy-
elitis and soft tissue tumours [8].
Cytology and Histology
Grains need to be isolated from lesions in order to identify
causative agents of mycetoma to the species level. This is usually
performed by a deep-seated biopsy or with fine needle aspiration
cytology (FNAC) (Figure 3). The latter was described in 1991 and
fully evaluated by Yousif and colleagues in 2010 [16]. In this
technique, a fine needle attached to a syringe is inserted into the
lesion by applying negative pressure and moving the needle up
and down in at least three different directions so that sufficient
aspirated material can be obtained. This material is usually bloody
and is therefore left to clot, then examined either by eye or
microscopically after fixation in 10% formalin-saline and staining
Figure 2. Imaging techniques used in mycetoma. A: A radiograph of the foot, showing soft tissue shadow (arrow), and multiple large cavities (c)
in line with eumycetoma. B: A typical sonogram of scrotal eumycetoma. In this sonogram multiple cavities with thick walls and multiple hyper-
reflective echoes (arrow) are seen, which are in line with grains. C: An MRI of the foot, showing massive soft tissue and bone destruction. In this MRI,
grains appear as conglomerates of small (2–5 mm) round hyperintense lesions (arrow).
doi:10.1371/journal.pntd.0002918.g002
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with haematoxylin and eosin (H&E) [16]. Yousif examined 230
mycetoma patients using FNAC and the cell block technique to
examine the grains of Actinomadura madurae, Actinomadura pelletierii,
Streptomyces somaliensis, and Madurella mycetomatis and the tissue
response to mycetoma. The technique had sensitivities of 87.5%
and 85.7% for eumycetoma and actinomycetoma, respectively
[16].
The identification of causative agents of mycetoma based on
histology has been performed since the 1950s [17]. Grains can be
identified in H&E stained sections (Figure 1), but special stains
are essential for in-depth identification of the causative organisms
[17,18]. Gram stains, such as Gram Weigert, can be used to
examine actinomycetoma tissue [18]. Periodic acid-Schiff (PAS),
Gomori methenamine silver, and Gridley are the most useful
stains for detecting hyphae and chlamydospores in eumycetoma
grains [18]. Chufal and colleagues published a strategy in 2012 to
identify causative agents based on histology (Figure 4) [19]. It can
be seen from this figure that it is not possible to differentiate
between Nocardia strains at the species level based on histology
[20,21]. Round, oval, or vermiform structures, which stain
eosinophilic with haematoxylin, are found [17]. The delicate
actinomycete filaments that may fragment into coccoid forms can
be shown by Gram stain [17]. A. pelletieri grains, which stain red
or dark blue with hematoxylin, consist of several lobules of
geometric appearance with denticulate edges that resemble a
broken dish [17]. In contrast, A. madurae grains have a central
eosinophilic area surrounded by a densely packed zone of dark
hematoxylin-stained filaments [17]. Peripherally, an eosin
stained fringe with pseudoclub shaped structures can be observed
[17].
Eumycetoma grains can be divided into black and pale grains.
The most common causative agent is M. mycetomatis [4]. In
histology sections, two types of grains of this agent are seen:
filamentous and vesicular [22]. The filamentous type is the most
common and consists of brown septate and branched hyphae
that may be slightly more swollen towards the periphery [22].
The vesicular type is composed of unusually large cells which
look like vesicles. Both types of grain can be found in the same
lesion [22]. A brown granular cement material is present inside
most of the grains [17]. In the black grains of Falciformispora
senegalensis (synonym: Leptoshaeria senegalensis) and Trematosphaeria
grisea (synonym: Madurella grisea) the centre is non-pigmented and
cement is absent, whereas at the peripheries the grains are dark
coloured and brown cement is present [17]. It is difficult to
distinguish between F. senegalensis and T. grisea based on histology
alone, but according to Mariat and Verghese, the borders of F.
senegalensis grains are less even and more crenelated, the
peripheral zones show larger vesicles while the hyphae at the
periphery show a more irregular arrangement [17]. Pale grain
eumycetoma caused by Scedosporium boydii (synonym: Pseudal-
lescheria boydii), Acremonium spp. and Fusarium spp. are similar
histopathologically and almost impossible to distinguish from
each other [21]. There are some features that might be helpful in
recognizing individual organisms [23]; for instance, in Sc. boydii
vesicles are usually noted, though this feature cannot be used
diagnostically [21,23] as some Acremonium kiliense grains also have
vesicles. In order to identify Sc. boydii more reliably on
histological slides, Hagari and associates performed a nested
PCR with Sc. boydii specific primers on paraffin-embedded
histology slides (Table 3) [24].
In summary, histology can be used to differentiate actinomy-
cetoma and eumycetoma, while FNAC is a fast technique that
may aid in choosing proper treatment. Histology cannot be relied
upon for definitive species identification; hence, confirmation
based on other techniques is needed.
Table 1. Radiographic classification of bone involvement in mycetoma as described by Abd El Bagi [7].
Stage Pattern of Spread Effect Findings
0 Limited to entry side Soft-tissue swelling No bone involvement
I Expanding granuloma Extrinsic pressure Displacement or scalloping
II Impending bone invasion Bone irritation Periosteal reaction or reactive sclerosis
III Localized bone invasion Erosion or cavitation Solitary bone involvement
IV Longitudinal spread Joint involvement Localized along single ray
V Horizontal spread Invasion of adjacent structures Localized to forefoot, midfoot, or hindfoot
VI Multidirectional spread Total disruption Multiple rays and multiple rows involved
Table adapted from Abd El Bagi et al. [7].
doi:10.1371/journal.pntd.0002918.t001
Table 2. MRI classification of mycetoma lesions based on the
Mycetoma Skin, Muscle, and Bone Grading (MSMB) system
according to El Shamy et al. [15].
Score MRI finding
Skin and subcutaneous tissue
0 No skin or subcutaneous involvement
1 Obliteration of skin and fascial planes
2 Abscess formation
3 Formation of sinus tract without grains
4 Formation of sinus tract with grains
Muscle
0 No muscle involvement
1 Muscle oedema
2 Formation of micro-abscess
3 Formation of macro-abscess
Bone
0 No bone involvement
1 Bone oedema
2 Bone cavitation
3 Bone destruction
Table adapted from El Shamy et al. [15].
doi:10.1371/journal.pntd.0002918.t002
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Culture and Phenotypic Characterisation of
Colonies
Viable grains need to be taken from lesions in order to grow
causative agents of mycetoma [25]. Since grains should be free of
contaminants, a deep-seated surgical biopsy is needed [8,25].
Grains collected from discharges of open sinuses are often non-
viable and contaminated [8]. Some of the collected grains should
be directly crushed in 10% KOH and used for microscopy; the
remainder are used for culture [26].
Actinomycetoma grains can be identified using Gram and
Ziehl-Neelsen (ZN) stains [8]. Gram staining can demonstrate the
gram-positive hyphae of filamentous actinomycetes; the ZN stain
is usually used for the identification of Nocardia spp. Fungal
filaments can be stained with calcofluor white or cotton blue [27].
In order to culture the causative agents, grains are usually
washed several times in sterile saline, crushed with a sterile glass
rod, and plated onto appropriate media [8,25]. If direct
examination of the grain reveals evidence of actinomycetes,
isolation media should not contain antibiotics [18]. Blood, brain-
heart infusion, Lo¨wenstein, and modified Sabouraud agar
supplemented with 0.5% yeast extract are commonly recom-
mended for the isolation of actinomycetes [8,18]. If direct
examination of grains is indicative of eumycetoma, grains can be
additionally washed with antibiotics and spread over Sabouraud
agar plates supplemented with antibiotics. Commonly used
antibiotics are gentamicin sulphate (400 mg/ml), penicillin G
(20 U/ml), streptomycin (40 mg/ml), or chloramphenicol (50 mg/
ml) [18]. It is also advisable to include a plate without antibiotics,
since the growth of some Madurella and actinomycete strains
appear to be inhibited by these antibiotics. Plates should be
incubated at 25uC and 37uC irrespective of whether the causative
agent is bacterial or fungal in origin (Figure 5).
After culture, presumptive species identification can be based on
micromorphological and cultural properties [25]. Nocardiae are
partially acid-alcohol fast positive and typically produce substrate
and aerial hyphae that fragment into rod- and coccoid-like
elements streptomycetes form a yellowish substrate mycelium and
lack aerial hyphae, and A. madurae and A. pelletieri strains produce
cream- and red-pigmented substrate mycelial respectively and on
initial isolation tend to lack aerial hyphae [28,29]. For eumyce-
toma, identification is mainly based on the morphology of the
fruiting bodies (if present) [18]. For species such as Madurella, in
which sporulation is usually not observed, the chance for
misidentification is common. Furthermore, for M. mycetomatis,
various colony morphologies have been observed, which makes
identification even more troublesome [18]. Differentiation be-
tween T. grisea and Medicopsis romeroi (synonym: Pyrenochaeta romeroi) is
also difficult. Although T. grisea is usually sterile, some isolates are
known to produce abortive pycnidia like those formed by Med.
romeroi [18]. Also differentiation of the various dematiaceous fungi,
such as Exopiala spp., based solely on morphology is sometimes
difficult, especially since some of these fungi only express yeast
morphology on isolation, and initial subculture and conidiogenesis
can only be induced after considerable manipulation [30].
For species identification of actinomycetes, phenotypic proper-
ties and assimilation tests can be performed, as exemplified by the
use of API 20C, API ZYM and API Coryne kits for the
identification of Nocardia species [31–33]. However, API 20C
assimilation results have been found to be variable within Nocardia
species, which makes definitive identification difficult [32]. When
the assimilation of adonitol, galactose, glucose, glycerol, inositol,
N-acetyl-D-glucosamine, and trehalose were considered reasonable,
discrimination between Nocardia species was obtained, though
results were not 100% specific [32]. In contrast, with the API
ZYM system distinct enzymatic profiles were obtained for Nocardia
asteroides, Nocardia brasiliensis and Nocardia otitidiscaviarum, though
other pathogenic species of Nocardia could not be separated by this
assay [33]. Further, N. brasiliensis was differentiated from Nocardia
farcinica using API Coryne kits [31]. Antibiotic susceptibility
patterns have also been used to identify various Nocardia spp.,
notably those based on amikacin, gentamicin, and tobramycin
[32]. Since neither assimilation patterns nor susceptibility profiles
alone were able to identify Nocardia species, Kiska and colleagues
proposed a stepwise approach for species identification starting
with susceptibility profiles and adding assimilation patterns and
pigment production to the identification algorithm [32]. In this
way, eight clinically relevant Nocardia species were identified [32].
However, the addition of several pathogenic species to the genus
Nocardia makes it difficult to know whether such phenotypic tests
can be weighted for identification in the future.
For the delineation of pathogenic Streptomyces spp. the following
phenotypic properties are of value: production of b-glucuronidase;
aesculin hydrolysis; degradation of adenine, casein and hypoxan-
thine; growth on adonitol, glycerol, glycogen, meso-inositol, D-
raffinose, L-rhamnose, D-turanose, D-xylose and L-aspartic acid
as sole carbon sources [28]. Furthermore, growth at 50uC and
pH 11.0 provide additional data of diagnostic value [28]. A.
madurae and A. pelletieri can be separated from most other
actinomycetes by the detection of chymotrypsin using the API
ZYM system. In addition, A. madurae was found to be positive for
a-glucosidase and negative for N-acetyl-b-glucosaminidase, while
for A. pelletieri the opposite was found [33].
Limited information is available on phenotypic properties and
assimilation patterns for eumycetoma agents; therefore, these
pathogens are still mainly identified solely by morphology. T. grisea
can be distinguished from M. mycetomatis based on the presence of a
secreted pigment and the assimilation of lactose, but not sucrose by
M. mycetomatis [27]. It remains to be seen whether this simple system
can be used to identify recently classified Madurella species, namely
M. fahalii, M. pseudomycetomatis and M. tropicana using API 20C AUX
kits [34]. M. pseudomycetomatis was found to assimilate arabinose,
cellulose, glucose, maltose, trehalose, and xylose, though such tests
have yet to be applied to the two other Madurella species [34].
Similarly, for Sc. boydii, an array of physiology and assimilation
patterns have been determined [35] but have not been routinely
used to distinguish other species. Carbohydrate and nitrate
assimilation have been determined for Exophiala spp., though it is
very difficult to differentiate between these species solely on this
Figure 3. Obtaining grains via Fine Needle Aspiration.
doi:10.1371/journal.pntd.0002918.g003
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basis [30]. E. dermatitidis and E. jeanselmei have very similar
assimilation patterns and can only be differentiated from one
another based on NaNO3 assimilation [30].
In summary, culture methods are still considered to be the gold
standard in species identification of the causal agents of mycetoma;
however, some agents are difficult to identify by morphology alone.
Furthermore, most culture methods are time consuming, contamina-
tion is common, and experience is needed to read results accurately.
Skin Tests
In order to develop a fast diagnostic tool, skin tests were
developed in the past and applied with some success. When
protein derivatives of N. brasiliensis were intradermally adminis-
tered in a dose of 0.2 mg in 0.1 ml, all of the patients infected with
this organism reacted positively to this antigen with indurations of
.6 mm in diameter, while none of the tuberculosis patients or
healthy adults showed a positive reaction [36]. However, a single
mycetoma patient infected with A. madurae did not give a positive
reaction in the skin test. When culture filtrate antigens were
prepared in 0.1 ml quantities from A. pelletieri, S. somaliensis and M.
mycetomatis, positive skin reactions were found in patients infected
with either A. madurae or S. somaliensis using the A. pelletieri and S.
somaliensis antigens after 5 hours and after 24 hours, but not
against M. mycetomatis [37]. Four out of the 13 M. mycetomatis
eumycetoma patients gave a positive skin reaction against the M.
mycetomatis antigen within 5 hours, though only one gave a positive
reaction after 24 hours [37]. Furthermore, five patients reacted
with the A. pelletieri and S. somaliensis antigens after 5 hours but not
after 24 hours, demonstrating that this skin test was not useful in
diagnosing eumycetoma [37].
Serology
Due to the invasive procedures needed to obtain grains and the
long incubation times needed for identification of causative agents,
attempts have been made to develop serological assays for the
diagnosis of mycetoma.
Immunodiffusion (ID), counter-immuno-electrophoresis (CIE),
and Enzyme Linked ImmunoSorbent Assays (ELISA) have been
developed to detect mycetoma caused by A. madurae, A. pelletieri,
and S. somaliensis using crude cytoplasmic antigens of these agents
[38–41]. CIE and immunodiffusion are two techniques that are
based on the formation of antibody-antigen precipitin lines in agar
gels [38,42]. Gumaa and Mahgoub demonstrated that from 200
sera negative by immunodiffusion, 76 sera reacted in the CIE;
hence, they concluded that CIE was more sensitive than ID in the
diagnosis of mycetoma [38]. McLaren compared ELISA with CIE
and found that while the former was more sensitive, it gave weak
positive reactions in some of the Egyptian and Sudanese controls.
This background reaction was reduced when the cytoplasmatic
antigens were centrifuged for 30 minutes at 20,000 g, indicating
that the pure antigens are necessary to produce a reliable
diagnostic serological tool [41].
Serological tests have been developed for N. asteroides and N.
brasiliensis using purified antigens from culture supernatants of
these organisms. SDS-PAGE was used to demonstrate that a 54–
55 kDA antigen found in culture media was present in N. asteroides,
N. brasiliensis, and N. otitidiscaviarum [43]. From dot blot and western
blot analysis it was demonstrated that the antigen reacted with sera
from N. brasiliensis-, N. asteroides-, and R. rhodochrous-infected
patients, but not with sera from healthy controls [43]. Surprisingly,
in the dot blot analysis one out of two A. madurae-positive patients
Figure 4. Flow diagram of histological identification of causative agents of mycetoma, based on references [18,19,23].
doi:10.1371/journal.pntd.0002918.g004
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also reacted with this antigen [43]. In the Western blot analysis,
sera from nocardiosis patients and one out of five tuberculosis
patients also reacted positively.
More discriminatory antigens were identified by Vera-Cabrera
and Salinas-Carmona and colleagues [43,44]. They identified
immunodominant proteins of 24 kDa (named P24) and 61 kDa
(named P61) by SDS-PAGE and purified them by Sephadex
purification and dialysis, respectively. In 1993, an ELISA was
developed with the purified p24 protein and tested against
mycetoma, leprosy, and tuberculosis patients. All 26 mycetoma
patients gave absorbance values equal to or above 0.3, whereas the
serum samples from 53 tuberculosis and leprosy patients or from
healthy controls had absorbance values below this level. Several
sera were available for analysis of five mycetoma patients during,
before, and after therapy. During active disease, absorbance values
were always above 0.3, but when patients were treated and
classified as cured, the absorbance levels dropped below this level.
This showed that the assay could be useful for monitoring
therapeutic responses [44]. Furthermore, antibody titres dropped
in patients who were cured and increased in those who presented
reactivation [44].
Serological assays have been developed to detect infections
caused by M. mycetomatis and Sc. boydii. An indirect hemaggluti-
nation assay (IHA) and an ID assay with crude antigens were
developed for Sc. boydii [39,45]. In the IHA, a partially purified
polysaccharide antigen isolated from Sc. boydii was coupled to
sheep erythrocytes, and a serial two-fold dilution of the patient
serum was added [45]. It appeared that five patients had antibody
levels ranging from 1:16 to 1:512, and the healthy controls’
antibody levels ranged from 1:4 to 1:32 in endemic areas.
The ID and CIE methods have been more widely used,
especially for M. mycetomatis [38,39]. In these assays, crude
Table 3. Primers used for molecular diagnostics.
Species Target
Forward primer
Sequence (59R39)
Reverse primer
Sequence (59R39)
Probe
Sequence (59R39) Size (bp) Reference
Streptomyces spp. 16S rRNA AGAGTTTGATMTGGCTCAG AAGGAGGTGWTCCARCC 1363 to 1521 [28]
Nocardia spp. 16S rRNA ACCGACCACAAGGGG GGTTGTAACCTCTTCGA 596 [54]
Nocardia spp. 16S rRNA GCTTAACACATGCAAGTCG GAATTCCAGTCTCCCCTG 606 [31]
Nocardia spp. 16S rRNA AGAGTTTGATCCTGGCTCAG ATTACCGCGGCTGCTGG 498 [59]
Nocardia spp. 16S-23S rRNA
intergenic
spacer
GTGCGGCTGGATCACCTCCT GACAGCTCCCCGAGGCTTATC-
GCA
various [58]
Nocardia spp. hsp65 ACCAACGATGGTGTGTCCAT CTTGTCGAACCGCATACCCT 441 [55,59]
Nocardia spp. hsp65 GTTGTCCTGGAGAAGAAGTGG CTTGTCGAACCGCATACCCT 476 [59]
Nocardia spp. gyrB CTTCGCCAACACCATCAACAC TGATGATCGACTGGACCTCG 610 [59]
Nocardia spp. gyrB CGAGGAGGGCTTCCGCGCGG ATCGACTGGACCTCGTTGTTC 521 [59]
Nocardia spp. secA1 GCGACGCCGAGTGGATGG TTGGCCTTGATGGCGTTGTTC 483 [59]
Nocardia spp. secA1 GCGACGCCGAGTGGATGG GCGGACGATGTAGTCCTTGTC 520 [59]
Nocardia spp. rpoB CCGCTACAAGATCAACAAGA-
AGC
CCCGCGAGGACATCGTCG 737 [59]
Nocardia spp. rpoB CCGCTACAAGATCAACAAGA-
AGC
GGCGACGTACTCCATCTCCTC 780 [59]
Nocardia spp. rpoB CCCGCGAGGACATCGTCG CCCGCGAGGACATCGTCG 655 [59]
Nocardia spp. rpoB CGAGTACCTGGTGCGYCTGC TCGACCGGCGAGTTGGCCTG 599 [59]
Fungi ITS TTACGTCCCTGCCCTTTGTA GCATTCCCAAACAACTCGACTC Various [64]
Fungi ITS TCCTCCGCTTATTGATATGC GGAAGTAAAAGTCGTAACAAGG Various [67]
M. mycetomatis ITS AATGAGTTGGGCTTTAACGG TCCCGGTAGTGTAGTGTCCCT 420 [67]
Sc. boydii ITS GAGGCAATAACAGGTCT-
GTGATGC
TTACTACGCAGAAGGCAA 800 [68]
Sc. boydii ITS AATCTTTGAACGCACATTG TTACTACGCAGAAGGCAA 197 [24]
Sc.boydii ITS TGTCCGAGCGTCATTTC TTACTACGCAGAAGGCAA 149 [24]
Sc. boydii ITS ATGGGCACCGAAGAAGCA CGCGCAGACACGATA pGGGTCGCGAAGACT
CGCCGTAgatcaTGCT
TCTTCGGTGCCCAT
taccggtgcggatagctac
CGCGCAGACACGATA
gtctaTTTCAGGGCCT
ACGGA
Various* [70]
Sc.boydii BT2 TGGCGAGCACGGTCTTG ACATTCACGGCAGACACTGATT FAM-TAGCAACGGA-
GTGTACGGAACCA-
CCC-BBQ
96** [69]
* Rolling Circle amplification assay, probe listed is the padlock probe to be used in this assay.
** quantitative real time PCR assay.
doi:10.1371/journal.pntd.0002918.t003
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cytoplasmatic antigens extracted only with saline or precipitated
by acetone are used [39]. Positive precipitation bands were found
in all sera from patients with proven and presumed M. mycetomatis
mycetoma when M. mycetomatis antigens were used and the same
was true for Sc. boydii [39]. Later it appeared that the
immunodiffusion assay could be negative in some patients with
mycetoma, especially ones receiving treatment or with early lesions
[38]. CIE appeared to be superior to ID in terms of sensitivity for
eumycetoma [38,39], as was the case for actinomycetoma.
ELISAs have been developed to define if there are more
sensitive and specific tools to determine the antibody response to
mycetoma antigens. The ELISA developed by Wethered and
colleagues was produced with crude extracts and could discrim-
inate between patients and controls [46]. The ELISA produced by
McLaren and colleagues was less reliable: out of nine healthy
controls tested, four were positive with no clinical sign of
mycetoma [41]. Taha and colleagues demonstrated that with
their ELISA, both mycetoma patients and uninfected controls
living in endemic areas had antibodies formed against mycetoma
agents [40]. Consequently, in endemic areas, only CIE has been
used for the diagnosis of mycetoma. Recently, the Mycetoma
Research Centre in Khartoum stopped using this assay because
the lack of standardization of the antigen preparation resulted in a
variation in the outcome of this diagnostic tool. The partially
purified antigens for both CIE and other serological tools are
prepared by grinding mycelia in saline, disintegrating them
ultrasonically, and collecting the cytoplasmatic proteins by
centrifugation [26,46,47]. Production of such antigens may result
in variation between tests. A serological assay based on a
recombinant antigen is to be preferred.
Recombinant antigens have been produced for M. mycetomatis.
The only serological tools which use recombinant antigens are
the ELISA described by van de Sande and colleagues [48] and
the Luminex described by de Klerk and associates [49]. The
recombinant translationally controlled tumour protein (TCTP)
was included in both assays. The Luminex assay also included
recombinant fructose-bisphosphate aldolase (FBA) and pyruvate
kinase (PK) antigens [48,49]. With these recombinant antigens it
was noted that although patients gave higher antibody levels,
healthy controls also produce antibodies against them, making it
impractical to use these recombinant antigens as diagnostic
tools.
In summary, serological tools provide a cheap and relatively fast
way to identify mycetoma causative agents, though to achieve
reliable results it is necessary to use standardized antigen
preparations. For N. brasiliensis a reliable serological tool has been
developed with the purified p24 protein, but for the other
causative agents of mycetoma reliable serological diagnostic tools
are not yet available.
Molecular Techniques
Difficulties associated with the accurate identification of the
known causative agents of actinomycetoma using phenotypic
criteria promoted the development and application of molecular
diagnostic procedures. Reliable identification of causal agents to
the genera Actinomadura, Nocardia, and Streptomyces can be achieved
by PCR and sequencing of conserved genes, notably, by
comparison of almost complete 16S rRNA gene sequences of
isolates against corresponding sequences of their phylogenetic
neighbours drawn from databases using software such as
EzTaxon-e [50] and appropriate clustering algorithms. In
contrast, identification of pathogenic actinomadurae, nocardiae,
and streptomycetes to the rank of species remains problematic.
Several molecular methods have been developed for the
identification of aerobic, filamentous, clinically significant actino-
mycetes, notably nocardiae. These include the use of PCR coupled
with restriction endonuclease analysis of the resultant products
[51–55] and PCR of randomly amplified polymorphic DNA
fingerprints [56]. Similar approaches based on 16S rRNA gene
polymorphisms have also been employed [57].
Wehrhahn and colleagues developed a PCR procedure for
identification and subtyping of Nocardia species based on the 16S–
23S intergenic spacer region that resulted in the generation of
amplicons of different sizes; these were analysed using a cost-
effective sequencer-based capillary gel electrophoretic system [58].
This method was used to correctly identify 142 out of the 145
tested isolates to the correct species [58]. McTaggart developed a
multilocus sequence analysis (MLSA) based on sequencing of 16S
rRNA genes, the b subunit of type II DNA topoisomerase (gyrB)
genes, the subunit A of SecA preprotein translocase (secA1) genes,
hsp65 genes, and RNA polymerase (rpoB) genes [59]. This method
was used to reliably identify Nocardia species, but the three-loci
(gyrB-16S-secA1) or four-loci (gyrB-16S-sefcA1-hsp65) MLSA was
nearly as reliable and is more amenable for use in the diagnostic
clinical microbiology laboratories [59].
Molecular diagnostic procedures have led to significant
improvements in the identification of aerobic, pathogenic actino-
mycetes, though there is evidence that the results of such studies
need to be interpreted with care if the misidentification of unusual
isolates is to be avoided [60–62]. Again, the long-term diagnostic
value of current molecular-based procedures is difficult to foresee,
given the need to apply them to an ever-expanding number of
Actinomadura, Nocardia, and Streptomyces species. This problem is
compounded by evidence that key pathogenic species, such as A.
madurae and N. asteroides, are heterogeneous [29,63]. Consequently,
unusual or potentially novel causal agents of actinomycetoma need
to be compared with their immediate neighbour(s) in 16S rRNA
gene trees prior to the application of additional diagnostic
procedures known to have traction at the rank of species.
The molecular identification of the causal agents of
eumycetoma is mainly based on the internal transcribed spacer
(ITS) that is located between the 18S and 28S genes. By using
the pan-fungal ITS primers and by either sequencing or
digesting the resulting PCR product with restriction-endonu-
cleases, causative agents can be identified to the species level
[64–67]. A PCR developed for M. mycetomatis using primers
located within the ITS region appears to be specific, as
amplification was not detected when DNA from T. grisea,
Biatriospora mackinnonii (synonym: Pyrenochaeta mackinnonii), and
Med. romeroi were used [67]. Molecular diagnostic tools have
been developed for Sc. boydii, but most of these assays are based
on the b-tubulin gene (BT2) and not on the ITS gene, as the
BT2 gene is more discriminatory. The PCR developed for the
ITS region by Wedde and associates, for instance, not only
amplified Sc. boydii but also Pseudallescheria augusta and Pseudal-
lescheria ellipsoidea [68]. A quantitative real time PCR (qPCR)
procedure with a probe specific for Sc. boydii and Scedosporium
apiospermum (Table 3) has been developed, though some cross-
reactivity was observed with Scedosporium minutispora [69].
For endemic countries, with only limited resources, species
identification based on PCR and sequencing or PCR and
restriction endonuclease analyses is still expensive; hence, efforts
have been made to perform species identification of the causal
agents of mycetoma through cheaper methods. One such method
is the Rolling Circle Amplification (RCA) technique, which is
designed to identify Sc. boydii and is based on the amplification of
the ITS region with pan-fungal primers (Table 3). After
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amplification, species identification is performed by hybridizing
species-specific padlock probes to the amplified ITS product and
ligated [70]. By adding the pan-fungal RCA primers and the Bst
DNA polymerase, species-specific amplification is performed for
60 minutes at 65uC. If amplification occurs, the result can be
analysed on gels. Unfortunately this procedure still relies on the
amplification of the ITS gene, and for some endemic countries, the
thermocyclers needed to perform the PCR are not routinely
available. The Loop-mediated Isothermal Amplification (LAMP)
method was developed for the identification of Sc. boydii (Table 4)
[69]. Genomic DNA can be amplified using this technique by
adding the six primers listed in Table 4 and Bst DNA polymerase
and incubating for 60 minutes at an isothermal temperature of
63uC [69]. The resulting product can be visualised either by Gel-
electrophoresis or by visual observation after the addition of SYBR
green. This method is suitable for species identification in endemic
Figure 5. Identifying mycetoma causative agents by culture. A: Madurella mycetomatis grown on sabouraud agar. B: Microscopic appearance
of Madurella mycetomatis stained with calcofluor white. C: N. brasiliensis colony. D: Microscopic appearance of N. brasiliensis.
doi:10.1371/journal.pntd.0002918.g005
Table 4. Primers used for LAMP.
Species Target Primer Sequence (59R39) Reference
Scedosporium boydii BT2 ATGGCACTTCTGAACTCCAG [69]
CGAGATCTACAAGGACAGCG
CTTGAGCGCATGAGCGTT
AACCAGCCCGTGGTTTGAACC
TTTGTTGCCCGAAGCCTAT
GTGTGGTGTCATCCAGCCTCC
doi:10.1371/journal.pntd.0002918.t004
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countries, especially since only simple extraction methods are
needed, based on Whatman FTA [69].
Conclusions
Diagnostic tools have been developed to aid in the diagnosis of
mycetoma, but most of them cannot be used alone. Clinical
examination and different imaging techniques can determine the
extent of the disease and, to some extent, its type. A first indication
of the causative agent can be obtained by isolating grains from
lesions with a fine needle aspirate. Further assessment can be
achieved by simply looking at the color of grains. More reliable
data can be gleaned by looking at grains histologically, but the
definite identification of causative agents of mycetoma should be
done only after culture and preferably by using appropriate
molecular tools.
The main drawback of molecular-based diagnostic tools is that
they usually have to be performed in large diagnostic centers, such
as referral hospitals in Mexico or specialized clinics in Sudan.
Since most of the patients do not live near such health facilities,
expensive travel is often necessary. Efforts need to be made to
develop easy bedside and field-based diagnostic tools to aid in the
identification of causative agents to the species level and to
prescribe proper treatment accordingly. For this, comparative
genomics of the already sequenced genomes of N. brasiliensis [71]
and S. somaliensis [72], and the genomes of other causative agents
which might be sequenced in the future will provide essential data
for developing species-specific identification tools. Procedures
already useful for such bedside implications include the LAMP-
based molecular diagnostic tools for Sc. boydii and agglutination
based serological tools.
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